| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Australia | 1.0 | 1.1 | | | | | | |
| Rest of world | 0.1 | 0.1 | | | | | | |
| United States | 10.3 | 8.3 | | | | | | |
| Other | 2.1 | 1.8 | | | | | | |
| Total revenues | 13.6 | 11.3 | 3.3 | 9.1 | 9.9 | 3.4 | 4.0 | 3.5 |
| Revenue growth [+] | 20.4% | 244.4% | -63.9% | -8.2% | 192.2% | -16.0% | 14.1% | |
| Australia | -4.3% | | | | | | | |
| Rest of world | 20.2% | | | | | | | |
| United States | 24.4% | | | | | | | |
| Cost of goods sold | 5.3 | 5.0 | 3.0 | 5.4 | 4.8 | 2.8 | 2.5 | 2.9 |
| Gross profit | 8.3 | 6.3 | 0.3 | 3.7 | 5.1 | 0.6 | 1.5 | 0.6 |
| Gross margin | 61.4% | 55.4% | 10.1% | 40.4% | 51.3% | 17.2% | 38.0% | 17.7% |
| Selling, general and administrative [+] | 33.6 | 15.2 | 16.7 | 29.9 | 28.8 | 10.2 | 3.5 | 4.7 |
| Sales and marketing | 9.2 | 4.7 | | | | | | |
| General and administrative | 24.4 | 10.5 | | | | | | |
| Other selling, general and administrative | 9.2 | 4.7 | | | | | | |
| Research and development | 2.5 | 3.5 | 6.9 | 10.7 | 10.6 | 9.9 | 13.0 | 5.8 |
| EBITDA [+] | -25.8 | -10.8 | -22.8 | -36.4 | -34.1 | -19.3 | -14.8 | -9.7 |
| EBITDA growth | 138.9% | -52.6% | -37.5% | 6.8% | 76.4% | 30.8% | 52.6% | |
| EBITDA margin | -189.5% | -95.5% | -693.4% | -399.8% | -343.6% | -569.2% | -365.6% | -273.4% |
| Depreciation | 0.2 | 0.0 | 0.5 | 0.6 | 0.3 | 0.2 | 0.2 | 0.2 |
| EBITA | -26.0 | -10.8 | -23.2 | -37.0 | -34.4 | -19.5 | -14.9 | -9.8 |
| EBITA margin | -191.3% | -95.6% | -708.0% | -406.2% | -346.9% | -574.9% | -369.7% | -278.0% |
| Amortization of intangibles | 1.7 | 1.7 | | | | | | |
| EBIT [+] | -27.7 | -12.5 | -23.2 | -37.0 | -34.4 | -19.5 | -14.9 | -9.8 |
| EBIT growth | 122.8% | -46.4% | -37.2% | 7.5% | 76.3% | 30.6% | 51.8% | |
| EBIT margin | -204.0% | -110.2% | -708.0% | -406.2% | -346.9% | -574.9% | -369.7% | -278.0% |
| Non-recurring items [+] | 28.8 | | | | | | | |
| Asset impairment | 28.8 | | | | | | | |
| Interest expense | 0.8 | 2.0 | 0.4 | 0.2 | 0.1 | 0.5 | 0.5 | 0.2 |
| Interest expense | 0.8 | 2.0 | 0.4 | 0.2 | 0.1 | 0.5 | 0.5 | 0.2 |
| Other income (expense), net [+] | -4.7 | -7.3 | 0.0 | -0.2 | -0.2 | -0.5 | -0.1 | 0.2 |
| Gain (loss) on debt retirement | -2.1 | -7.7 | | | | | | |
| Gain (loss) on foreign currency transactions | -0.2 | -0.4 | | | | | | |
| Change in fair value of warrants | | | | | | -0.5 | 0.0 | 0.2 |
| Other | | | -0.1 | -0.2 | -0.2 | 0.0 | 0.0 | 0.0 |
| Pre-tax income | -62.0 | -21.8 | -23.7 | -37.4 | -34.8 | -20.5 | -15.6 | -9.9 |
| Income taxes | -0.1 | -0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.2% | 0.8% | | | | | 0.1% | |
| Net income | -61.9 | -21.6 | -23.7 | -37.4 | -34.8 | -20.5 | -15.6 | -9.9 |
| Net margin | -455.4% | -191.4% | -721.6% | -410.7% | -350.7% | -603.2% | -385.2% | -279.5% |
| |
| Basic EPS [+] | ($5.00) | ($5.54) | ($5.03) | ($19.64) | ($2.08) | ($4.85) | ($27.14) | ($18.61) |
| Growth | -9.7% | 10.1% | -74.4% | 844.2% | -57.1% | -82.1% | 45.8% | |
| Diluted EPS [+] | ($5.00) | ($5.54) | ($5.03) | ($19.64) | ($2.08) | ($4.85) | ($27.14) | ($18.61) |
| Growth | -9.7% | 10.1% | -74.4% | 844.2% | -57.1% | -82.1% | 45.8% | |
| |
| Shares outstanding (basic) [+] | 12.4 | 3.9 | 4.7 | 1.9 | 16.7 | 4.2 | 0.6 | 0.5 |
| Growth | 217.0% | -17.0% | 147.2% | -88.6% | 296.0% | 636.6% | 7.9% | |
| Shares outstanding (diluted) [+] | 12.4 | 3.9 | 4.7 | 1.9 | 16.7 | 4.2 | 0.6 | 0.5 |
| Growth | 217.0% | -17.0% | 147.2% | -88.6% | 296.0% | 636.6% | 7.9% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |